154 related articles for article (PubMed ID: 34363346)
1. Bone marrow dosimetric analysis of lymphopenia in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy.
Wang Q; Qiu Q; Zhang Z; Zhang J; Yang G; Liu C; Li B
Cancer Med; 2021 Sep; 10(17):5847-5858. PubMed ID: 34363346
[TBL] [Abstract][Full Text] [Related]
2. Less Irradiation to Lymphocyte-Related Organs Reduced the Risk of G4 Lymphopenia in Esophageal Cancer: Re-Analysis of Prospective Trials.
Tseng I; Li F; Ai D; Chen Y; Xu Y; Yu L; Hao S; Zhu H; Deng J; Liu Q; Pan F; Su F; Zhao K
Oncologist; 2023 Aug; 28(8):e645-e652. PubMed ID: 37285035
[TBL] [Abstract][Full Text] [Related]
3. Lymphopenia During Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Association with Dosimetric Parameters and Patient Outcomes.
Xu H; Lin M; Hu Y; Zhang L; Li Q; Zhu J; Wang S; Xi M
Oncologist; 2021 Mar; 26(3):e425-e434. PubMed ID: 32960471
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organs.
Tseng I; Ai D; Chen Y; Zhu H; Li F; Xu Y; Yu L; Liu Q; Deng J; Hao S; Zhu Z; Zhao W; Fan M; Li L; Su F; Zhao K
Radiat Oncol; 2023 Oct; 18(1):172. PubMed ID: 37858121
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Lymphopenia and Dosimetric Parameters on Overall Survival of Esophageal Cancer Patients Treated with Definitive Radiotherapy.
Liu M; Li X; Cheng H; Wang Y; Tian Y
Cancer Manag Res; 2021; 13():2917-2924. PubMed ID: 33833575
[TBL] [Abstract][Full Text] [Related]
6. Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?
Chadha AS; Liu G; Chen HC; Das P; Minsky BD; Mahmood U; Delclos ME; Suh Y; Sawakuchi GO; Beddar S; Katz MH; Fleming JB; Javle MM; Varadhachary GR; Wolff RA; Crane CH; Wang X; Thames H; Krishnan S
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):323-332. PubMed ID: 28068240
[TBL] [Abstract][Full Text] [Related]
7. Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and Chemoradiotherapy.
Cheng X; Chen B; Wang S; Zhang J; Zhu J; Liu M; Liu S; Xi M
Oncologist; 2023 Aug; 28(8):e606-e616. PubMed ID: 37061835
[TBL] [Abstract][Full Text] [Related]
8. Dose-volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation.
Sini C; Fiorino C; Perna L; Noris Chiorda B; Deantoni CL; Bianchi M; Sacco V; Briganti A; Montorsi F; Calandrino R; Di Muzio N; Cozzarini C
Radiother Oncol; 2016 Jan; 118(1):79-84. PubMed ID: 26702990
[TBL] [Abstract][Full Text] [Related]
9. Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy.
Zhou XL; Zhu WG; Zhu ZJ; Wang WW; Deng X; Tao WJ; Ji FZ; Tong YS
Oncologist; 2019 Aug; 24(8):e677-e686. PubMed ID: 31040254
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implication of simultaneous anemia and lymphopenia during concurrent chemoradiotherapy in cervical squamous cell carcinoma.
Cho O; Chun M; Oh YT; Noh OK; Chang SJ; Ryu HS; Lee EJ
Tumour Biol; 2017 Oct; 39(10):1010428317733144. PubMed ID: 29022484
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric analysis of lymphopenia during chemoradiotherapy for esophageal cancer.
Newman NB; Anderson JL; Sherry AD; Osmundson EC
J Thorac Dis; 2020 May; 12(5):2395-2405. PubMed ID: 32642145
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort.
Qi WX; Wang X; Li C; Li S; Li H; Xu F; Chen J; Zhao S; Li H
Thorac Cancer; 2023 Jun; 14(17):1556-1566. PubMed ID: 37089116
[TBL] [Abstract][Full Text] [Related]
13. Survival Comparision of Three-dimensional Radiotherapy Alone vs. Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.
Zhang AD; Su XH; Shi GF; Han C; Wang L; Liu H; Zhang J; Zhang RH
Arch Med Res; 2020 Jul; 51(5):419-428. PubMed ID: 32418649
[TBL] [Abstract][Full Text] [Related]
14. Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy.
Pao TH; Chang WL; Chiang NJ; Chang JS; Lin CY; Lai WW; Tseng YL; Yen YT; Chung TJ; Lin FC
Radiat Oncol; 2020 Sep; 15(1):221. PubMed ID: 32962730
[TBL] [Abstract][Full Text] [Related]
15. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma.
Wu H; Yu Y; Zheng Q; Liu T; Wu Y; Wang Z; Zheng H; Liu L; Li J
Radiat Oncol; 2021 Oct; 16(1):207. PubMed ID: 34717670
[TBL] [Abstract][Full Text] [Related]
16. Spleen Dose-Volume Parameters as a Predictor of Treatment-related Lymphopenia During Definitive Chemoradiotherapy for Esophageal Cancer.
Saito T; Toya R; Yoshida N; Shono T; Matsuyama T; Ninomura S; Watakabe T; Sasaki Y; Baba H; Oya N
In Vivo; 2018; 32(6):1519-1525. PubMed ID: 30348711
[TBL] [Abstract][Full Text] [Related]
17. The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy.
Deng W; Xu C; Liu A; van Rossum PSN; Deng W; Liao Z; Koong AC; Mohan R; Lin SH
Radiother Oncol; 2019 Apr; 133():9-15. PubMed ID: 30935587
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy.
Xu X; Wang Z; Jiang S; Shang Y; Wu Y
Radiat Oncol; 2019 Nov; 14(1):191. PubMed ID: 31684983
[TBL] [Abstract][Full Text] [Related]
19. Clinical and dosimetric predictors of acute hematologic toxicity in rectal cancer patients undergoing chemoradiotherapy.
Yang TJ; Oh JH; Apte A; Son CH; Deasy JO; Goodman KA
Radiother Oncol; 2014 Oct; 113(1):29-34. PubMed ID: 25304718
[TBL] [Abstract][Full Text] [Related]
20. Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma.
Rudra S; Hui C; Rao YJ; Samson P; Lin AJ; Chang X; Tsien C; Fergus S; Mullen D; Yang D; Thotala D; Hallahan D; Campian JL; Huang J
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):217-225. PubMed ID: 29502931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
